One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine

NCT00142337 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

244

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Zidovudine (ZDV)
DRUG: Didanosine (ddI)

Sponsor

Institut de Recherche pour le Developpement